Our research group at UCL Biochemical Engineering is pioneering the convergence of artificial intelligence (AI) and automation within the realm of synthetic biology. With the help of our collaborators in UK, USA and Europe, we  are developing advanced platforms that leverage AI algorithms to enhance automation systems, with the ultimate goal of accelerating research and innovation in synthetic biology. Our work aims to bring a new level of precision, efficiency, and scalability to automated biological experiments.


The complexity and intricate nature of biological systems often make synthetic biology experiments resource-intensive and time-consuming. By integrating AI into automation, we are enhancing the capacity to handle this complexity, thereby revolutionizing how experiments are planned, executed, and analyzed. This integration is not merely incremental; it represents a transformative approach to tackling some of the most pressing challenges in biotechnology and medicine.

Techniques and Tools

Our research utilizes a multi-disciplinary toolkit that encompasses both computational and biological methodologies:

  • AI Algorithms: Utilizing machine learning, neural networks, and reinforcement learning to optimize experimental parameters and predict outcomes.
  • Open Source Robotic Automation: Employing advanced robotic systems capable of handling biological samples, reagents, and executing multi-step protocols.
  • Real-Time Monitoring: Implementing sensors and data analytics tools to provide real-time feedback, which is further analyzed by AI for adaptive process control.
  • Data-Driven Optimization: Utilizing AI to analyze large datasets for pattern recognition, thereby improving the efficiency and reliability of automated systems.


The impact of our research is multifaceted and extends across various domains:

  • High-Throughput Screening: AI-enhanced automation enables the rapid screening of biological variables for applications such as drug discovery or metabolic engineering.
  • Personalized Medicine: Automated platforms can be tailored to conduct experiments that take into account individual genetic variations, advancing the field of personalized medicine.
  • Resource Optimization: Our systems can intelligently allocate resources and prioritize experiments, significantly reducing costs and time.
  • Accelerated Research: With more efficient and intelligent systems, the pace of discovery in synthetic biology is poised for unprecedented acceleration.